Apolipoprotein CIII, Human Plasma,
Very Low Density Lipoprotein
Product Number 16-16-120303
MW 8,750
Frozen in 10 mM NH4HCO3, pH 7.4
Storage: Freezer
Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml.
Purity: >=95% by SDS-PAGE
Prepared from fresh, non-frozen plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.
Athens Research & Technology products are laboratory reagents and are not to be administered to humans or used for any drug purpose. For research use only.
Return to full proteins list
